Share Price | Cingulate, Inc. Stock Analysis & Recommendation

Q: How big is Cingulate, Inc.?

Market Cap: As of Jun 18, Cingulate, Inc. has a market capitalization of 18.89 million, categorizing it as a Micro Cap company.Recent Quarterly Performance: For the latest four quarters, Cingulate, Inc. reported net sales of 0.00 million and a net profit of -16.37 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 7.46 million and total assets of 14.86 million.

Q: What does Cingulate, Inc. do?

Overview:Cingulate, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.Financial Snapshot:Most recent Net Profit: -4 Million (Quarterly Results - Mar 2025) Market Cap: USD 18.89 Million (Micro Cap)Key Metrics:P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.75 Return on Equity: -276.12% Price to Book: 3.19Contact Details:Registrar Address: Not available.

Q: Is Cingulate, Inc. technically bullish or bearish?

As of 9 September 2025, the technical trend for Cingulate, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is bearish, while the monthly MACD is mildly bullish. The Bollinger Bands are bearish on both weekly and monthly time frames. Daily moving averages show a mildly bullish trend. The KST is mildly bearish weekly and bearish monthly, and Dow Theory indicates a mildly bearish weekly trend with no trend monthly. Cingulate's performance has been significantly underwhelming compared to the S&P 500, with a year-to-date return of -28.6% versus the S&P's 12.22%, and a one-year return of -28.74% compared to the S&P's 17.14%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

166.85 k

Shareholding (Sep 2025)

FII

0.23%

Held by 5 FIIs

DII

98.24%

Held by 2 DIIs

Promoter

0.00%

How big is Cingulate, Inc.?

22-Jun-2025

As of Jun 18, Cingulate, Inc. has a market capitalization of 18.89 million, categorizing it as a Micro Cap company, with net sales of 0.00 million and a net profit of -16.37 million over the latest four quarters. As of Dec 24, the company reported shareholder's funds of 7.46 million and total assets of 14.86 million.

View full answer

What does Cingulate, Inc. do?

22-Jun-2025

Cingulate, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $4 million and a market cap of $18.89 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -276.12%.

View full answer

Is Cingulate, Inc. technically bullish or bearish?

20-Sep-2025

As of September 9, 2025, Cingulate, Inc. shows a neutral trend with mixed signals, including a bearish weekly MACD and mildly bullish monthly MACD, while underperforming the S&P 500 with a year-to-date return of -28.6%.

View full answer

Compare Cingulate, Inc. with Similar Stocks

Aytu Biopharma, Inc.RenovoRx, Inc.Biofrontera, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 37 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.78

Return on Equity

-624.88%

Price to Book

10.76

Revenue and Profits:

Net Sales:

(Quarterly Results - Sep 2025)

Net Profit:

-7 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

75.41%

6 Months

15.69%

1 Year

42.32%

2 Years

-59.34%

3 Years

555.56%

4 Years

-98.52%

5 Years

0.0%

Cingulate, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

13.49%

EBIT to Interest (avg)

-26.31

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.75

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

8.13%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.12

EV to EBIT

-0.86

EV to EBITDA

-0.89

EV to Capital Employed

9.42

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-1098.18%

ROE (Latest)

-276.12%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 2 Schemes (1.53%)

Foreign Institutions

Held by 5 Foreign Institutions (0.23%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -78.05% vs 31.67% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.90",
          "val2": "-3.10",
          "chgp": "-90.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-7.30",
          "val2": "-4.10",
          "chgp": "-78.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 34.04% vs -32.77% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-15.00",
          "val2": "-22.20",
          "chgp": "32.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-15.50",
          "val2": "-23.50",
          "chgp": "34.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-5.90

-3.10

-90.32%

Interest

0.00

Exceptional Items

-0.40

0.00

Consolidate Net Profit

-7.30

-4.10

-78.05%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -78.05% vs 31.67% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-15.00

-22.20

32.43%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-15.50

-23.50

34.04%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 34.04% vs -32.77% in Dec 2023

All Annual Results

Company CV

About Cingulate, Inc.

Cingulate, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Cingulate, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Cingulate, Inc.?

Watch in Real-Time

What does Cingulate, Inc. do?

Is Cingulate, Inc. technically bullish or bearish?

Compare Cingulate, Inc. with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Cingulate, Inc.

Company Coordinates